BR0009551A - Pharmaceutical suspension for drinking - Google Patents

Pharmaceutical suspension for drinking

Info

Publication number
BR0009551A
BR0009551A BR0009551-6A BR0009551A BR0009551A BR 0009551 A BR0009551 A BR 0009551A BR 0009551 A BR0009551 A BR 0009551A BR 0009551 A BR0009551 A BR 0009551A
Authority
BR
Brazil
Prior art keywords
drinking
pharmaceutical suspension
suspension
pharmaceutical
weight
Prior art date
Application number
BR0009551-6A
Other languages
Portuguese (pt)
Inventor
Christophe Lebon
Emmanuel Guerin
Pascal Suplie
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of BR0009551A publication Critical patent/BR0009551A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"SUSPENSãO FARMACêUTICA PARA BEBER". Esta invenção refere-se a uma suspensão farmacêutica para beber em que a fração solúvel do ou dos princípios ativos que ela contém é inferior a 1 0% em peso em relação ao peso da suspensão."PHARMACEUTICAL SUSPENSION TO DRINK". This invention relates to a pharmaceutical suspension for drinking in which the soluble fraction of the active ingredient (s) it contains is less than 10% by weight relative to the weight of the suspension.

BR0009551-6A 1999-04-06 2000-04-06 Pharmaceutical suspension for drinking BR0009551A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9904251A FR2791888B1 (en) 1999-04-06 1999-04-06 ORAL PHARMACEUTICAL SUSPENSION
PCT/FR2000/000870 WO2000059468A1 (en) 1999-04-06 2000-04-06 Drinkable pharmaceutical solution

Publications (1)

Publication Number Publication Date
BR0009551A true BR0009551A (en) 2002-05-28

Family

ID=9544041

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0009551-6A BR0009551A (en) 1999-04-06 2000-04-06 Pharmaceutical suspension for drinking

Country Status (9)

Country Link
EP (1) EP1165043A1 (en)
CN (1) CN1351488A (en)
AU (1) AU778364B2 (en)
BR (1) BR0009551A (en)
FR (1) FR2791888B1 (en)
HU (1) HUP0200711A3 (en)
IL (1) IL145768A0 (en)
WO (1) WO2000059468A1 (en)
ZA (2) ZA200108116B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030039687A1 (en) * 2001-08-01 2003-02-27 Michael Corbo Taste masking composition
US7300670B2 (en) * 2002-04-03 2007-11-27 Unilab Pharmatech, Ltd. Oral suspension formulation
KR20170052626A (en) 2014-09-05 2017-05-12 심바이오믹스 세러퓨틱스 엘엘씨 Secnidazole for use in the treatment of bacterial vaginosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
DE3900811A1 (en) * 1989-01-13 1990-07-19 Kali Chemie Pharma Gmbh NEW MEDICINE
IE902829A1 (en) * 1989-08-14 1991-02-27 Eurand America Microencapsulated taste-masked water-insoluble nsaid drug¹materials
IL104093A (en) * 1991-12-31 1999-06-20 Abbott Lab Prolamine coatings for taste-masking orally administrable medicaments
BR9505962A (en) * 1994-12-21 1997-12-23 Johnson & Johnson Aqueous pharmaceutical suspension and process for its preparation
CA2219758A1 (en) * 1995-05-09 1996-11-14 Jamesina Anne Fitzgerald Compositions comprising bismuth and one or more antimicrobials, for the treatment and prevention of gastrointestinal disorders

Also Published As

Publication number Publication date
CN1351488A (en) 2002-05-29
WO2000059468A1 (en) 2000-10-12
IL145768A0 (en) 2002-07-25
AU3825200A (en) 2000-10-23
ZA200108206B (en) 2002-12-24
FR2791888B1 (en) 2004-10-08
AU778364B2 (en) 2004-12-02
ZA200108116B (en) 2002-09-25
FR2791888A1 (en) 2000-10-13
HUP0200711A2 (en) 2002-07-29
HUP0200711A3 (en) 2003-04-28
EP1165043A1 (en) 2002-01-02

Similar Documents

Publication Publication Date Title
BR0212986A (en) Imizadol-4-carboxamide derivatives, preparation and use for obesity treatment
TR200003735T2 (en) Prevention and treatment of disorders related to osteoporosis and menopause syndrome
BRPI0316532B8 (en) pharmaceutical compositions comprising a basic or acidic drug, a surfactant, and a physiologically tolerable water-soluble acid or base
BRPI0416752B8 (en) pharmaceutical composition, use of one or more compounds, and compounds
BR0007556A (en) Tweak and tweak receptor antagonists and their use to treat immune disorders
ECSP067043A (en) USEFUL PIRROLOTRIAZINE DERIVATIVES TO TREAT HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS
PT1181027E (en) DIETETIC OR PHARMACEUTICAL COMPOSITION FOR USE IN THE PREVENTION OR TREATMENT OF HYPEROXALURY
BRPI9809468B8 (en) Pharmaceutical formulations containing voriconazole
MXPA02002249A (en) Palatable pharmaceutical compositions for companion animals.
WO2000015205A3 (en) Use of acetylcholinesterase inhibitors for the preparation of pharmaceutical compositions for the treatment of functional and/or organic pain syndromes
PT1328268E (en) COMBINATION OF CATHETER AND QUERCETINE FOR PHARMACEUTICAL OR DIETETIC USE
BR0009594A (en) Compound derived from amine or a pharmacologically acceptable salt thereof, drug, insulin tolerance enhancing agent, blood sugar lowering agent, immunoregulatory agent, aldose reductase inhibiting agent, 5-lipoxygenase inhibiting agent, formation inhibiting agent lipid peroxide, ppar activating agent, antiosteoporosis agent, leukotriene antagonist agent, fat cell promoting agent, cancer cell proliferation inhibiting agent or calcium antagonist agent, pharmaceutical composition and use of a compound
FR2857596B1 (en) USE OF A COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A LUPEOL-RICH EXTRACT AS AN ACTIVE INGREDIENT TO STIMULATE THE SYNTHESIS OF STRESS PROTEINS
MA29723B1 (en) COMPOUNDS
BR0013009A (en) Use of cgrp antagonists and cgrp release inhibitors to combat menopausal hot jets
NO20000310L (en) Pharmaceutical compositions containing vitamin D and calcium, their preparation and therapeutic use
BR0015540A (en) Adenosine receptor antagonists and methods of preparing and using them
EP1032556A4 (en) Pharmaceutically active compounds and methods of use
EP1736470A3 (en) Pyrimidine derivatives as CB2 cannabinoid receptor modulators
BR0009551A (en) Pharmaceutical suspension for drinking
BR0008382A (en) Controlled release formulation for copd treatment
WO2000054780A3 (en) Corticosteroid formulation
BR0015172A (en) New combination comprising a beta 2 adrenaline agonist (beta 2) and a leukotriene receptor antagonist
BR0009557A (en) Pharmaceutical suspension for ibuprofen drinking
BR9812531A (en) Combination of components, pharmaceutical preparation, production thereof, and use of the combination or pharmaceutical preparation

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.